Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
29 nov. 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the...
Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs
01 nov. 2018 08h18 HE
|
Clinical Genomics
Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for...
Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer
26 oct. 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy...
Two new Board of Director appointments to liquid biopsy company Clinical Genomics
16 oct. 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to the company’s...
Clinical Genomics is proud to support Strides for Life and Super Bowel I
24 août 2018 09h00 HE
|
Clinical Genomics
Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24,...
Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health
14 juin 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...
Biotech with Liquid Biopsy for Colorectal Cancer Secures $26 Million in New Funding
01 juin 2018 08h30 HE
|
Clinical Genomics
Clinical Genomics drives the commercialization of Colvera™, a liquid biopsy test service for colorectal cancer (CRC) recurrence and the focus of growing clinical evidence to support its use as the...
Clinical Genomics Presents Clinical Utility Data for COLVERA™ at 2018 ASCO Annual Meeting
24 mai 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer (CRC) testing and solutions, today announced that data demonstrating the utility of...
Clinical Genomics Pathology Inc. receives licensure from Florida Agency for Healthcare Administration
06 mars 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...
Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening
01 févr. 2018 08h30 HE
|
Clinical Genomics
BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than...